Pharmafile Logo
Pharmafocus logo
Advanced Search

Scancell Holdings plc: Interim Results for the 6 months ended 31 October 2022

January 25, 2023
Business Services

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces …

News
Press release

Sosei Heptares Webinar Presentation for FY2022 Financial Results

January 25, 2023
Business Services

Tokyo, Japan and Cambridge, UK, 25 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release

Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug

January 25, 2023
Medical Communications

Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug …

News

Eli Lilly plans to invest $450m at production site in Research Triangle Park

January 25, 2023
Manufacturing and Production

US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …

News

Poxel given EC’s Orphan Drug Designation for rare metabolic disorders

January 25, 2023
Research and Development

Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …

News

Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1

January 25, 2023
Medical Communications

US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It …

News

finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation

January 24, 2023
Business Services

London, 24th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the …

News
Press release

UK seeing exodus of R&D activity, research reveals

January 24, 2023
Business Services

London, 24 January 2023: The UK is experiencing a crisis where firms are moving R&D activity abroad, according to research …

News
Press release

Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence

January 24, 2023
Business Services

London, UK and Antwerp, Belgium. 24th January 2023 – Amber Therapeutics (‘Amber’ or the ‘Company’), a University of Oxford spinout …

News
Press release

2022 Novo Holdings Seed Investments team Review/Business Update

January 24, 2023
Business Services

Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …

News
Press release

Global Company Foot Science International Choose Onyx Health

January 24, 2023
Business Services

Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …

News
Press release

Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg

January 24, 2023
Business Services

Brussels and Düsseldorf – January 24, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …

News
Press release

Europe plans further antibiotic shortage countermeasures

January 24, 2023
Medical Communications

With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to …

News

WHO issues a “call to action” after cough syrup deaths

January 24, 2023
Medical Communications

WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, …

News

TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes

January 24, 2023
Research and Development

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …

News

Novo Nordisk accused of violating FDA’s Fair Balance advertising policy

January 24, 2023
Sales and Marketing

Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo …

News

Modus Therapeutics submits patent application for sevuparin in kidney disease

January 23, 2023
Business Services

STOCKHOLM, SWEDEN – 23 January 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …

News
Press release

Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)

January 23, 2023
Business Services

Dublin, Ireland – January 23, 2023 – Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound …

News
Press release

First Indian intranasal COVID-19 vaccine about to launch

January 23, 2023
Medical Communications

Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ …

News

FDA awards CardioRenal Systems Breakthrough Device Designation for RenalGuard Therapy

January 23, 2023
Medical Communications

The FDA has granted Breakthrough Device Designation for US-based medical technology company CardioRenal for their RenalGuard Therapy device, used to …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026